BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
DTAB Suggests Setting Up a Single Licensing & Approval Authority for Drugs in India March 12, 2024 Calls for centralized regulation in India surged due to reported adverse effects and fatalities abroad due to India-made medicines.
DTAB Recommends Affixing QR Code on all Vaccine Products March 11, 2024 The Drugs Technical Advisory Board (DTAB) has proposed affixing barcodes or QR codes on all vaccine products to regulate vaccine distribution and usage in the country.
Govt Updates PTUAS Scheme to Meet Industry Demands March 8, 2024 The Union Government has approved amendments to the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) to bolster support for enhancing quality standards within the pharmaceutical sector.
Venus Remedies Nets INR 7.5 Cr under PLI Scheme March 7, 2024 Haryana-based pharmaceutical company Venus Remedies has secured its initial disbursement of INR 7.5 Cr under the central government's Production Linked Incentive (PLI) scheme.
Roche Pharma Ventures into Ophthalmology, Launches Antibody to Treat Vision Loss March 6, 2024 Pharmaceutical player Roche India has marked its entry into the country's ophthalmology market with the launch of Vabysmo (faricimab), a monoclonal antibody.
CDSCO Releases Revised Guidelines on Post-Approval Changes in Biological Products March 6, 2024 The Central Drugs Standard Control Organisation (CDSCO) has unveiled a draft of revised guidance for the industry concerning quality, safety, and efficacy documents for Post Approval Changes (PACs) in biological products.
CDSCO Shifts PSUR Submission Online March 1, 2024 To modernize regulatory procedures, the Central Drugs Standard Control Organisation (CDSCO) has shifted the submission process for Period Safety Update Reports (PSUR) concerning the marketing authorization of new drugs and others to an online system.
Roche Introduces Ocrevus for Multiple Sclerosis Treatment in India February 29, 2024 Roche Pharma India has launched Ocrevus (ocrelizumab), a novel drug for treating multiple sclerosis (MS), aiming to address the unmet needs of patients grappling with this debilitating disease in India.
Takeda Partners with Hyd-Based Biological E. for Dengue Vaccine Manufacturing February 28, 2024 In an effort to combat the global threat of dengue fever, Takeda Pharmaceutical Company has entered into a strategic partnership with Hyderabad-based Biological E., a biotechnology and biopharmaceutical company.
PM Modi Unveils Advanced Level Research Centre to Strengthen Pharma Sector February 27, 2024 ALRC is expected to contribute to pharmaceutical standardization and the availability of high-quality and safe medicines at affordable costs in India.
IPC Releases Draft Pharmacovigilance Guidance Document to Strengthen Standard February 26, 2024 The Indian Pharmacopoeia Commission (IPC) has stepped towards bolstering pharmacovigilance standards in India by releasing the Draft Pharmacovigilance Guidance Document for Pharmaceutical Products Version 2.0.
Parl Panel Recommends Overhaul of Pharma Export Schemes February 21, 2024 The Parliamentary Standing Committee on Commerce has proposed several revisions to key schemes to bolster the country’s pharmaceutical space.
